Development of a new formulation combining calcipotriol and betamethasone dipropionate in an ointment vehicle

Drug Development and Industrial Pharmacy

Volumn 30, Issue 10, 2004, Pages 1095-1102

  Simonsen, Lene ^a   Høy, Gert ^a   Didriksen, Erik ^a   Persson, Jette ^a   Melchior, Nina ^a   Hansen, Jens ^a  

^a LEO PHARMA A S   (Denmark)

Author keywords

Betamethasone dipropionate; Calcipotriol; Daivobet ; Formulation; Skin permeation

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL; LANOLIN;

ANIMAL TISSUE; ARTICLE; DRUG MIXTURE; DRUG PENETRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; OINTMENT; SKIN PENETRATION; SKIN PERMEABILITY; SWINE;

ADMINISTRATION, TOPICAL; BETAMETHASONE; CALCITRIOL; CHEMISTRY, PHARMACEUTICAL; DENMARK; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG DESIGN; HUMANS; OINTMENTS; PERMEABILITY; SKIN; SOLUBILITY; VEHICLES;

EID: 9644282985     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-200040297     Document Type: Article

References (19)

1. Greaves, M.W.; Weinstein, G.D. Treatment of psoriasis. N. Engl. J. Med. 1995, 332 (9), 581-588.
2. van de Kerkhof, P.C.; Vissers, W.H. The topical treatment of psoriasis. Skin Pharmacol. Appl. Skin Physiol. 2003, 16 (2), 69-83.
3. Cunliffe, W.J.; Berth-Jones, J.; Claudy, A.; Fairiss, G.; Goldin, D.; Gratton, D.; Henderson, C.A.; Holden, C.A.; Maddin, W.S.; Ortonne, J.P. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J. Am. Acad. Dermatol. 1992, 26 (5), 736-743.
4. Kragballe, K.; Gjertsen, B.T.; De Hoop, D.; Karlsmark, T.; van de Kerkhof, P.C.; Larko, O.; Nieboer, C.; Roed-Petersen, J.; Strand, A.; Tikjob, G. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991, 337 (8735), 193-196.
5. Kragballe, K.; Barnes, L.; Harnberg, K.J.; Hutchinson, P.; Murphy, F.; Moller, S.; Ruzicka, T.; van de Kerkhof, P.C. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br. J. Dermatol. 1998, 139 (4), 649-654.
6. Lebwohl, M.; Siskin, S.; Epinette, W.; Breneman, D.; Funicella, T.; Kalb, R.; Moore, J. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J. Am. Acad. Dermatol. 1996, 35 (2), 268-269.
7. Ruzicka, T.; Lorenz, B. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br. J. Dermatol. 1998, 138 (2), 254-258.
8. Lebwohl, M. Topical application of calcipotriene and corticosteroids: combination regimens. J. Am. Acad. Dermatol. 1997, 37 (3), S55-S58.
9. Didriksen, E.; Høy, G. Pharmaceutical Composition; January 27, 2000, International patent application no. WO 00/64450.
10. Patel, B.; Siskin, S.; Krazmien, R.; Lebwohl, M. Compatibility of calcipotriene with other topical medications. J. Am. Acad. Dermatol. 1998, 38 (6), 1010-1011.
11. Loftsson, T.; Petersen, D.S. Cyclodextrin solubilization of water-insoluble drugs: Calcipotriol and EB-1089. Pharmazie 1997, 52 (10), 783-785.
12. Traulsen, J.; Hughes-Formella, B.J. The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment. Dermatology 2003, 207 (2), 166-172.
13. Franz, T.J. Percutaneous absorption, on the relevance of in vitro data. J. Invest. Dermatol. 1975, 64 (3), 190-195.
14. Skelly, J.P.; Shah, V.P.; Maibach, H.; Guy, R.H.; Wester, R.C.; Flynn, G.L.; Yacobi, A. FDA and AAPS report on the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm. Res. 1987, 4 (3), 265-267.
15. Dick, I.P.; Scott, R.C. Pig ear skin as an in-vitro model for human skin permeability. J. Pharm. Pharmacol. 1992, 44 (8), 640-645.
16. Douglas, W.S.; Poulin, Y.; Decroix, J.; Ortonne, J.P.; Mrowietz, U.; Gulliver, W.; Krogstad, A.L.; Larsen, F.G.; Iglesias, L.; Buckley, C.; Bibby, A.J. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm.-Venereol. 2002, 82 (2), 131-135.
17. Guenther, L.; van de Kerkhof, P.C.; Snellman, E.; Kragballe, K.; Chu, A.C.; Tegner, E.; Garcia-Diez, A.; Springborg, J. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br. J. Dermatol. 2002, 147 (2), 316-323.
18. Papp, K.A.; Guenther, L.; Boyden, B.; Larsen, F.G.; Harvima, R.J.; Guilhou, J.J.; Kaufmann, R.; Rogers, S.; van de Kerkhof, P.C.; Hanssen, L.I.; Tegner, E.; Burg, G.; Talbot, D.; Chu, A.C. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J. Am. Acad. Dermatol. 2003, 48(1), 48-54.
19. Kaufmann, R.; Bibby, A.J.; Bissonnette, R.; Cambazard, F.; Chu, A.C.; Decroix, J.; Douglas, W.S.; Lowson, D.; Mascaro, J.M.; Murphy, G.M.; Stymne, B. A new calcipotriol/betamethasone dipropionate formulation (daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 2002, 205 (4), 389-393.